Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 55

1.

Preoperative angiotensin-converting enzyme inhibitors and angiotensin receptor blocker use and acute kidney injury in patients undergoing cardiac surgery.

Coca SG, Garg AX, Swaminathan M, Garwood S, Hong K, Thiessen-Philbrook H, Passik C, Koyner JL, Parikh CR; TRIBE-AKI Consortium.

Nephrol Dial Transplant. 2013 Nov;28(11):2787-99. doi: 10.1093/ndt/gft405. Epub 2013 Sep 29.

2.

The impact of pay for performance on the control of blood pressure in people with chronic kidney disease stage 3-5.

Karunaratne K, Stevens P, Irving J, Hobbs H, Kilbride H, Kingston R, Farmer C.

Nephrol Dial Transplant. 2013 Aug;28(8):2107-16. doi: 10.1093/ndt/gft093. Epub 2013 May 7.

PMID:
23658247
3.

Prevalence of chronic kidney disease and its risk factors among family practice patients in Lithuania.

Bumblyte IA, Zilinskiene A, Vanholder R, Valius L, Kuzminskis V.

Clin Nephrol. 2012 Sep;78(3):198-206.

PMID:
22874108
4.

Diabetic nephropathy--the family physician's role.

Roett MA, Liegl S, Jabbarpour Y.

Am Fam Physician. 2012 May 1;85(9):883-9.

5.

GFR and cardiovascular outcomes after acute myocardial infarction: results from the Korea Acute Myocardial Infarction Registry.

Bae EH, Lim SY, Cho KH, Choi JS, Kim CS, Park JW, Ma SK, Jeong MH, Kim SW.

Am J Kidney Dis. 2012 Jun;59(6):795-802. doi: 10.1053/j.ajkd.2012.01.016. Epub 2012 Mar 23.

PMID:
22445708
6.

Serum HSP27 is associated with medullary perfusion in kidney allografts.

Marquez E, Sadowski E, Reese S, Vidyasagar A, Artz N, Fain S, Jacobson L, Swain W, Djamali A.

J Nephrol. 2012 Nov-Dec;25(6):1075-80. doi: 10.5301/jn.5000099.

PMID:
22383348
7.

A cluster randomized trial of an enhanced eGFR prompt in chronic kidney disease.

Manns B, Tonelli M, Culleton B, Faris P, McLaughlin K, Chin R, Gooch K, McAlister FA, Taub K, Thorlacius L, Krause R, Kearns M, Hemmelgarn B; Alberta Kidney Disease Network.

Clin J Am Soc Nephrol. 2012 Apr;7(4):565-72. doi: 10.2215/CJN.12391211. Epub 2012 Feb 16.

8.

Exposure to inhibitors of the renin-angiotensin system is a major independent risk factor for acute renal failure induced by sucrose-containing intravenous immunoglobulins: a case-control study.

Moulis G, Sailler L, Sommet A, Lapeyre-Mestre M, Montastruc JL; French Association of Regional Pharmacovigilance Centers.

Pharmacoepidemiol Drug Saf. 2012 Mar;21(3):314-9. doi: 10.1002/pds.2253. Epub 2011 Sep 28.

PMID:
21953992
9.

Effect of captopril treatment on recuperation from ischemia/reperfusion-induced acute renal injury.

Efrati S, Berman S, Hamad RA, Siman-Tov Y, Ilgiyaev E, Maslyakov I, Weissgarten J.

Nephrol Dial Transplant. 2012 Jan;27(1):136-45. doi: 10.1093/ndt/gfr256. Epub 2011 Jun 16.

10.

Atorvastatin improves tubular status in non-diabetic patients with chronic kidney disease - placebo controlled, randomized, cross-over study.

Renke M, Tylicki L, Rutkowski P, Neuwelt A, Larczyński W, Ziętkiewicz M, Aleksandrowicz E, Lysiak-Szydłowska W, Rutkowski B.

Acta Biochim Pol. 2010;57(4):547-52. Epub 2010 Nov 16.

11.

Effect of pentoxifylline on proteinuria, markers of tubular injury and oxidative stress in non-diabetic patients with chronic kidney disease - placebo controlled, randomized, cross-over study.

Renke M, Tylicki L, Rutkowski P, Knap N, Zietkiewicz M, Neuwelt A, Aleksandrowicz E, Łysiak-Szydłowska W, Woźniak M, Rutkowski B.

Acta Biochim Pol. 2010;57(1):119-23. Epub 2010 Mar 22.

12.

Angiotensin receptor blocker reduces proteinuria independently of blood pressure in children already treated with Angiotensin-converting enzyme inhibitors.

Seeman T, Pohl M, Misselwitz J, John U.

Kidney Blood Press Res. 2009;32(6):440-4. doi: 10.1159/000266478. Epub 2009 Dec 17.

PMID:
20016211
13.

Study of ACEI versus ARB in managing hypertensive overt diabetic nephropathy: long-term analysis.

Ozturk S, Sar F, Bengi-Bozkurt O, Kazancioglu R.

Kidney Blood Press Res. 2009;32(4):268-75. doi: 10.1159/000239765. Epub 2009 Sep 18.

PMID:
19776644
14.

[How to carry out the search of kidney disease in patients with cardiovascular disease?].

Górriz Teruel JL.

Med Clin (Barc). 2009 May;132 Suppl 1:6-12. doi: 10.1016/S0025-7753(09)70956-X. Spanish.

PMID:
19460474
15.

[Factors associated with reduced renal function post primary percutaneous coronary intervention in acute myocardial infarction patients with normal baseline serum creatinine level].

Liu ZY, Zhang SY, Shen ZJ, Fan ZJ, Fang Q, Zhu WL.

Zhonghua Xin Xue Guan Bing Za Zhi. 2008 May;36(5):408-11. Chinese.

PMID:
19100033
16.
17.

Agalsidase alfa slows the decline in renal function in patients with Fabry disease.

Feriozzi S, Schwarting A, Sunder-Plassmann G, West M, Cybulla M; International Fabry Outcome Survey Investigators.

Am J Nephrol. 2009;29(5):353-61. doi: 10.1159/000168482. Epub 2008 Oct 31. Review. Erratum in: Am J Nephrol. 2009;29(5):361.

PMID:
18974635
18.
19.

Improving care of patients with diabetes and CKD: a pilot study for a cluster-randomized trial.

Cortés-Sanabria L, Cabrera-Pivaral CE, Cueto-Manzano AM, Rojas-Campos E, Barragán G, Hernández-Anaya M, Martínez-Ramírez HR.

Am J Kidney Dis. 2008 May;51(5):777-88. doi: 10.1053/j.ajkd.2007.12.039.

PMID:
18436088
20.

Pregnancy in CKD stages 3 to 5: fetal and maternal outcomes.

Imbasciati E, Gregorini G, Cabiddu G, Gammaro L, Ambroso G, Del Giudice A, Ravani P.

Am J Kidney Dis. 2007 Jun;49(6):753-62.

PMID:
17533018
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk